Learning Objectives:

1.  To review the rationale and design of dose finding/adjustment trials/studies that implement novel pharmacokinetics and pharmacogenomics strategies toward personalized cancer treatment

2.  To review the role of evaluating the association of response to targeted therapies and tumoral heterogeneity in personalized cancer treatment

Session date: 
08/08/2022 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Koosha Paydary, MD, MPH, MSc